First Time Loading...
S

Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 17.92 CNY -0.78% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Shanghai Pharmaceuticals Holding Co Ltd

Wall Street analysts forecast Shanghai Pharmaceuticals Holding Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Pharmaceuticals Holding Co Ltd is 21.07 CNY with a low forecast of 12.52 CNY and a high forecast of 27.72 CNY.

Lowest Forecast
Wall Street Target
12.52 CNY
30% Downside
Average Forecast
Wall Street Target
21.07 CNY
18% Upside
Highest Forecast
Wall Street Target
27.72 CNY
55% Upside
Lowest
Price Target
12.52 CNY
30% Downside
Average
Price Target
21.07 CNY
18% Upside
Highest
Price Target
27.72 CNY
55% Upside
Shanghai Pharmaceuticals Holding Co Ltd Competitors:
Price Targets
SELEC.E
Selcuk Ecza Deposu Ticaret ve Sanayi AS
19% Upside
AMP
Amplifon SpA
12% Upside
7476
As One Corp
45% Upside
HAEK
Haemato AG
59% Upside
SELEC.E
Selcuk Ecza Deposu Ticaret ve Sanayi AS
19% Upside
AMP
Amplifon SpA
12% Upside
7476
As One Corp
45% Upside
HAEK
Haemato AG
59% Upside
Q
301015
Qingdao Baheal Medical Inc
61% Upside
FAGR
Fagron NV
18% Upside
4164
CHC Healthcare Group
33% Upside
000705
Zhejiang Zhenyuan Share Co Ltd
98% Upside

Revenue
Forecast

Revenue Estimate
Shanghai Pharmaceuticals Holding Co Ltd

For the last 8 years the compound annual growth rate for Shanghai Pharmaceuticals Holding Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 11%.

12%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shanghai Pharmaceuticals Holding Co Ltd

For the last 8 years the compound annual growth rate for Shanghai Pharmaceuticals Holding Co Ltd's operating income is 12%. The projected CAGR for the next 3 years is 13%.

12%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shanghai Pharmaceuticals Holding Co Ltd

For the last 8 years the compound annual growth rate for Shanghai Pharmaceuticals Holding Co Ltd's net income is 3%. The projected CAGR for the next 3 years is 13%.

3%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Pharmaceuticals Holding Co Ltd's stock price target?
Price Target
21.07 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai Pharmaceuticals Holding Co Ltd is 21.07 CNY with a low forecast of 12.52 CNY and a high forecast of 27.72 CNY.

What is Shanghai Pharmaceuticals Holding Co Ltd's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Shanghai Pharmaceuticals Holding Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 11%.

What is Shanghai Pharmaceuticals Holding Co Ltd's Operating Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Shanghai Pharmaceuticals Holding Co Ltd's operating income is 12%. The projected CAGR for the next 3 years is 13%.

What is Shanghai Pharmaceuticals Holding Co Ltd's Net Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Shanghai Pharmaceuticals Holding Co Ltd's net income is 3%. The projected CAGR for the next 3 years is 13%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.